Description: Rhinomed Limited is an Australia-based medical technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. The Company is involved in the identification, acquisition and commercialization of late-stage therapeutic delivery technologies. Its over-the-counter (OTC) products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics and sports stores. Its Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Its Mute is a nasal technology that is designed to allow the user to manage the sleep quality by breathing more and snoring less. Its Intranasal Positive Expiratory Air Pressure (INPEAP) technology is under development for the treatment of mild to moderate obstructive sleep apnea. In addition, the Company is involved in clinical programs that are focused on the olfactory pathway and wearable technology.
Home Page: www.rhinomed.global
RNO Technical Analysis
132 Gwynne Street
Cremorne,
VIC
3121
Australia
Phone:
61 3 8416 0900
Officers
| Name | Title |
|---|---|
| Mr. Michael Johnson | CEO, MD & Exec. Director |
| Mr. Sean Slattery | CFO & Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.9588 |
| Price-to-Sales TTM: | 3.2718 |
| IPO Date: | 2007-08-02 |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |